PSYCHIATRY DRUG ALERTS, VOLUME XXVIII, 2014 INDEX
|
|
- Gervase Dorsey
- 6 years ago
- Views:
Transcription
1 A acamprosate ADHD Generic Methylphenidate Equivalence, 84 Methylphenidate in Pregnancy, 9 Stimulants in Pregnancy, 50 adverse effects Antidepressant-Induced Jitteriness, 94 Antidepressants and Sexual Function, 22 Antidepressant Risperidone-Associated Gynecomastia, 63 Sertraline-Associated Maculopathy, 94 Venlafaxine Cardiac Effects, 54 Ziprasidone-Associated DRESS, 89 agitation Citalopram in Alzheimer s Disease, 29 agomelatine Clozapine Augmentation, 62 akathisia Fluvoxamine, 25 alcohol use disorders Medication Efficacy, 44 alprazolam Pseudopheochromocytoma, 86 Alzheimer s disease Benzodiazepine-Associated Risk, 85 Citalopram, 29 Idalopiridine, 84 Interferon Beta-1A, 23 Memantine plus Vitamin E, 12 amitriptyline amphetamine anticonvulsants. See also specific drugs antidepressants. See also specific drugs Bipolar Depression, 87 Gait Deficits in the Elderly, 50 Jitteriness/Anxiety Syndrome, 94 Long-Term Platelet Effects, 89 Polarity and Suicidal Behavior, 57 antiinflammatories. See also specific drugs antipsychotics. See also specific drugs Atypicals for Breast Cancer, 47 Dose Equivalents, 36 Fluvoxamine for Movement Disorders, 25 Metabolic Effects, 6, 31 Naltrexone for Weight Gain, 65 anxiety Vilazodone, 92, 93 anxiolytics. See also specific drugs. Pseudopheochromocytoma, 86 aripiprazole Augmentation in OCD, 90 Bipolar Depression, 87 Long-Acting Injection, 52, 70 armodafinil Augmentation in Depression, 1 Bipolar Depression, 82 arrhythmia Drug-Induced, 37 asenapine Bipolar Disorder, 81 Weight and Metabolic Effects, 6 atomoxetine Safety in Pregnancy, 50 atorvastatin
2 autism spectrum disorders SSRIs in Pregnancy, 10 B benzodiazepines. See also specific drugs Alzheimer s Risk, 85 Functional Decline in Older Adults, 46 bexarotene Schizophrenia, 11 bipolar affective disorder bipolar disorder Adjunctive Hormonal Treatment, 33 Antidepressants, Polarity, and Suicide, 57 Armodafinil, 82 Asenapine in Older Adults, 81 Asenapine Weight and Metabolic Effects, 6 Clozapine Rapid Titration, 60 Depression Treatments Compared, 79 Erythropoietin and Cognition, 71 Isradipine, 25 Levothyroxine, 4 Lurasidone, 19, 20 Modafinil Augmentation, 1 Naltrexone, 76 Olanzapine Monotherapy, 18 Pharmacotherapy Review, 87 Varenicline for Smoking Cessation, 14 bitopertin Negative Symptoms, 43 borderline personality disorder Quetiapine, 91 breast cancer Antipsychotics, 47 bupropion Safety in Pregnancy, 50, 55 C calcium channel blockers. See also specific drugs Isradipine in Bipolar Depression, 25 carbamazepine cariprazine Schizophrenia, 21 cholinesterase inhibitors. See also specific drugs Plus Vitamin E in Alzheimer s, 12 cigarette smoking Clozapine, Olanzapine Dose Adjustments, 34 citalopram Agitation in Alzheimer s Disease, 29 claustrophobia Methylene Blue and Fear Extinction, 77 clomipramine clonazepam Social Anxiety Disorder, 11 clonidine Sensory Gating in Schizophrenia, 67 clozapine Dose Adjustments in Nonsmokers, 34 Ivabradine for Tachycardia, 58 Metabolic Effects, 61 Plus Agomelatine in Schizophrenia, 62 Plus Ziprasidone in Schizophrenia, 28 Rapid Titration, 60 cognitive enhancers cognitive symptoms Adjunctive Ziprasidone in Schizophrenia, 28 congenital malformations Antidepressants in Pregnancy, 55 Methylphenidate in Pregnancy, 9 CP-601,927 Antidepressant Augmentation, 95
3 cyproterone acetate D daily defined dose method D-alanine D-cycloserine delirium Ramelteon, 37 depression Adjunctive Treatments, 78 Antidepressant Platelet Effects, 89 Antidepressant Extended-Release Levomilnacipran, 76 Lisdexamfetamine, 2 Mirtazapine in Diabetes, 73 Modafinil Augmentation, 1 Patient-Reported Outcomes, 68 Quetiapine and Suicidality, 49 Rellidep, 7 Statins Poststroke, 3 Transdermal Selegiline, 83 Vilazodone, 92, 93 Vortioxetine, 45 depression, bipolar Adjunctive Treatments, 78 Antidepressants, Polarity, and Suicide, 57 Armodafinil, 82 Asenapine in Older Adults, 81 Isradipine, 25 Levothyroxine, 4 Lurasidone, 19, 20 Modafinil Augmentation, 1 Olanzapine Monotherapy, 18 Pharmacotherapy Review, 87 Treatments Compared, 79 depression, resistant Intranasal Oxytocin, 75 Neurobiology, 51 desipramine desmopressin, intranasal Negative Symptoms of Schizophrenia, 27 desvenlafaxine diabetes Mirtazapine Metabolic Effects, 73 Statin, SSRI Comedication, 26 donepezil Cognitive Function in Schizophrenia, 59 Plus Idalopiridine, 84 dose equivalents Antipsychotics, 36 doxepin drug interactions. See also specific drugs SSRI/NSAID, 66 SSRI/Proton Pump Inhibitors, 47 SSRI/Statins, 26 Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Ziprasidone, 89 drug safety Eszopiclone Prolonged Impairment, 41 Methylphenidate in Pregnancy, 9 Psychotropics and Arrhythmia, 37 SSRIs in Pregnancy, 10 Stimulants in Pregnancy, 50 Venlafaxine Cardiac Safety, 54 Ziprasidone-Associated DRESS, 89 duloxetine dyslipidemia E G ecopipam Tourette Syndrome, 22 erythropoietin Cognition in Bipolar Disorder, 71
4 escitalopram Plus Intranasal Oxytocin in Depression, 75 esomeprazole eszopiclone Prolonged Impairment, 41 executive function Lisdexamfetamine in Depression, 2 exposure training Fear Extinction in Claustrophobia, 77 fear extinction Methylene Blue in Claustrophobia, 77 fetal exposure Antidepressants, 55 Methylphenidate, 9 SSRIs, 10 Stimulants, 50 fluoxetine fluvastatin fluvoxamine Antipsychotics and Movement Disorders, 25 folate functional decline Benzodiazepines, 46 gabapentin gait deficits Antidepressants in the Elderly, 50 galantamine gastrointestinal bleeding SSRI/NSAID Interaction, 66 generalized anxiety disorder Vortioxetine, 15 glutamate receptor Rellidep in Depression, 7 glycine goserelin gynecomastia Risperidone, 63 H L haloperidol hoarding disorder Venlafaxine, 35 hypertension hypertensive crisis Transdermal Selegiline, 83 idalopiridine Alzheimer s Disease, 84 iloperidone Antipsychotics Breast Cancer, 47 imipramine interferon beta-1a Early Alzheimer s Disease, 23 isocarboxacid isradipine Bipolar Depression, 25 ivabradine Clozapine-Induced Tachycardia, 58 lamotrigine
5 lansoprazole leptin Antidepressant Augmentation, 95 leuprolide acetate levomilnacipran, extended-release Depression, 76 levothyroxine Resistant Bipolar Depression, 4 lisdexamfetamine Executive Dysfunction in Depression, 2 lithium Bipolar Depression, 87 Plus Modafinil, 1 lovastatin lurasidone Bipolar Depression, 19, 20, 79, 87 M O maculopathy Sertraline, 94 mania Asenapine in Older Adults, 81 Hormonal Treatments, 33 MAOIs (monoamine oxidase inhibitors). See also individual drugs. Transdermal Selegiline in Depression, 83 medroxyprogesterone acetate Mania, 33 melatonin Olanzapine Weight Gain, 41 memantine Plus Vitamin E in Alzheimer s Disease, 12 metabolic effects Asenapine, 6 Antipsychotics, 6, 31 Clozapine, 61 Melatonin, 41 Mirtazapine in Diabetes, 73 metformin methylene blue Fear Extinction in Claustrophobia, 77 methylphenidate Generic Therapeutic Equivalence, 84 Fetal Exposure, 9 minimum effective dose method minocycline Negative Symptoms of Schizophrenia, 17 mirtazapine Diabetes, 73 Platelet Effects, 89 mixed episodes Asenapine in Older Adults, 81 modafinil Augmentation in Depression, 1 mood stabilizers. See also specific drugs Plus Modafinil, 1 nalmefene naltrexone Antipsychotic-Induced Weight Gain, 65 Bipolar Disorder, 76 nefazodone negative symptoms Adjunctive Desmopressin, 27 Adjunctive Minocycline, 17 Adjunctive Ziprasidone, 28 Bitopertin, 43 Emerging Treatments, 42 neurokinin-2 receptors Rellidep in Depression, 7
6 nicotinic acetylcholine receptor partial agonist CP-601,927 Augmentation in Depression, 95 nonsteroidal antiinflammatory drugs (NSAIDs). See also specific drugs SSRI Interaction, 66 nortriptyline obesity Antidepressant Augmentation, 95 OCD (obsessive-compulsive disorder) Atypical Antipsychotic Augmentation, 90 Ondansetron, 13 Venlafaxine for Hoarding, 35 olanzapine Bipolar Depression, 18, 79, 87 Dose Adjustments in Nonsmokers, 34 Melatonin for Weight Gain, 41 Plus Donepezil for Cognition, 59 Plus Modafinil, 1 olanzapine fluoxetine omeprazole ondansetron Resistant OCD, 13 oxytocin, intranasal Resistant Depression, 75 P,Q paliperidone pantoprazole paraphilias Pharmacotherapy Plus Psychotherapy, 53 Parkinson s disease Pimavanserin, 30 paroxetine Hoarding Disorder, 35 patient-reported outcomes Depression, 68 perphenazine pimavanserin Parkinson s Psychosis, 30 pimozide pitavastatin platelets Antidepressant Effects, 89 postpartum period Pharmacokinetic Changes, 38 pravastatin pregabalin pregnancy Antidepressant Cardiac Effects, 55 Methylphenidate Safety, 9 Pharmacokinetic Changes, 38 SSRIs and Autism Risk, 10 Stimulant Safety, 50 pregnenolone prolactin Risperidone-Associated Gynecomastia, 63 proton pump inhibitors (PPIs). See also specific drugs pseudopheochromocytoma Anxiolytic Withdrawal, 86 psychosis Pimavanserin in Parkinson s Disease, 30
7 psychostimulants QT prolongation Psychotropics, 37 quetiapine Borderline Personality Disorder, 91 Suicidality, 49 R, S ramelteon Delirium Prevention, 37 reboxetine rellidep Depression, 7 remission Vilazodone in Depression, 93 retinoid agonist Bexarotene in Schizophrenia, 11 risperidone Augmentation in OCD, 90 Bipolar Depression, 79 Desmopressin for Negative Symptoms, 27 Gynecomastia, 63 Plus Donepezil for Cognition, 59 Plus Minocycline for Negative Symptoms, 17 risperidone, long-acting injection Bipolar Depression, 87 rivastigmine rosuvastatin sarcosine schizoaffective disorder Adjunctive Hormonal Treatment, 33 Varenicline for Smoking Cessation, 14 schizophrenia Adjunctive Desmopressin, 27 Adjunctive Minocycline, 17 Adjunctive Ziprasidone, 28 Agomelatine, 62 Antipsychotic Dose in Nonsmokers, 34 Aripiprazole Long-Acting Injection, 52, 70 Asenapine Weight and Metabolic Effects, 6 Bexarotene, 11 Bitopertin, 43 Cariprazine, 21 Clonidine and Sensory Gating, 67 Donepezil for Cognition, 59 Melatonin for Olanzapine Weight Gain, 41 Naltrexone for Weight Gain, 65 Treating Negative Symptoms, 42 Treating Violent Patients, 74 Varenicline for Smoking Cessation, 14 selegiline, transdermal Depression, 83 sensory gating Clonidine in Schizophrenia, 67 sertindole sertraline Maculopathy, 94 Plus Clonazepam in Social Anxiety, 11 sexual dysfunction Antidepressants, 22 sibutramine sildenafil simvastatin
8 smoking cessation Varenicline Maintenance, 14 SNRIs (serotonin-norepinephrine reuptake inhibitors). See also specific drugs Hoarding Disorder, 35 Jitteriness/Anxiety Syndrome, 94 social anxiety disorder Clonazepam Augmentation, 11 sodium benzoate SSRIs (selective serotonin reuptake inhibitors). See also specific drugs Bipolar Depression, 79 Fetal Exposure and Autism Risk, 10 Hoarding Disorder, 35 Jitteriness/Anxiety Syndrome, 94 NSAID Interaction, 66 Platelet Effects, 89 Plus Atypicals in OCD, 90 Plus Clonazepam in Social Anxiety, 11 Plus Modafinil in Depression, 1 PPI Interaction, 47 Resistant Depression, 51 Statin Comedication, 26 statins Poststroke Depression, 3 SSRI Comedication, 26 stimulants Safety in Pregnancy, 50 stroke Statins and Depression, 3 suicide/suicidal behavior/suicidality Antidepressants and Polarity, 57 Quetiapine, 49 T tachycardia Clozapine-Induced, 58 tamoxifen Mania, 33 tardive dyskinesia Fluvoxamine, 25 TC-5619 TCAs (tricyclic antidepressants). See also specific drugs Jitteriness/Anxiety Syndrome, 94 therapeutic equivalence Generic Concerta, 84 topiramate Tourette Syndrome Ecopipam, 22 trazodone trimipramine triptorelin tyramine-free diet Transdermal Selegiline, 83 U Z valproic acid Plus Modafinil, 1 varenicline Maintenance for Smoking Prevention, 14 venlafaxine Cardiac Safety, 54 Hoarding Disorder, 35 Platelet Effects, 89 Plus Clonazepam in Social Anxiety, 11 vilazodone Depression, 92, 93 violence Schizophrenia Treatments, 74
9 vitamin E Alzheimer s Disease, 12 vortioxetine Depression, 45 Generalized Anxiety Disorder, 15 weight gain Antidepressants, 69 Antipsychotics, 6, 31 Asenapine, 6 Melatonin, 41 Mirtazapine in Diabetes, 73 Naltrexone, 65 ziprasidone Schizophrenia, 28
Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX
A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release
More informationSouth London and the Maudsley NHS Foundation Trust Medicines Formulary
South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics 4.1.1
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX
A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationDisclosure. Objectives: Technician. Objectives: Pharmacist. Diagnostic and Statistical Manual (DSM-V) The Face of Mental Illness 7/25/2015
49th Annual Meeting Psychiatry for the Non-Psychiatry Specialist Jacintha Cauffield, PharmD, BCPS, CDE Associate Professor of Pharmacy Practice Lloyd L. Gregory School of Pharmacy Palm Beach Atlantic University
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationObjectives. Mental Health Info MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES 11/12/2018
MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES Holly Altenberger, PharmD, RPh Director of Pharmacy O Connell Pharmacy holly@oconnellpharmacy.com Objectives At the conclusion of the
More informationJudges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY
ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More informationUse of Psychotropic Medications in Older Adults with Dementia!
Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with
More informationPrescriber s Guide. Stahl s Essential Psychopharmacology
Stahl s Essential Psychopharmacology Prescriber s Guide FIFTH EDITION With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present this
More informationGuidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Gene(s)/Level of evidence
Drug Gene(s)/Level of evidence Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Haloperidol CYP2D6 ( SLC6A5 ( 2D6: DPWG guidelines Reduce dose by 50% in PMs Aripiprazole
More informationMental Health DNA Insight WHITE PAPER
Mental Health DNA Insight WHITE PAPER JULY 2016 Mental Health DNA Insight / White Paper Mental Health DNA Insight Pathway Genomics Mental Health DNA Insight test is aimed to help psychiatrists, neurologists,
More informationMentoring Session: Participant Cases
Handout for the Neuroscience Education Institute (NEI) online activity: Mentoring Session: Participant Cases The Case: 55-year-old patient with depression and anxiety The Question: What to do when antidepressants
More informationINDEX. Index. in this web service Cambridge University Press
INDEX A absorption problems, 63 4 acetylcholine and extrapyramidal side effects, 59 60 memory pathways, 257 8 action potentials, ion flow, 29 30 aggression in dementia, citalopram for, 267 8 link to orbital
More informationIndex. E Elderly and dementia, 2 Epilepsy, 59 Escitalopram, 51, 87 Estazolam, 101 Extrapyramidal symptoms (EPS), 18
A Abilify, 143 Absolute neutrophil count (ANC), 29 Acetylcholine (Ach), 14, 15 ACTivities of daily living and cognition (ACTION) study, 167 AD Anti-inflammatory Prevention Trial (ADAPT) study, 156 Adverse
More informationEligible Beneficiaries
Therapeutic Class: Behavioral Health Medications for Adults Clinical Edit Number Long Description 4110 (May change) Quantity limit edit that is applied to atypical antipsychotics for claims identified
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More informationIndex. Index. More information
acamprosate, alcohol dependence, 223 225, 227 228, 252 acetylcholine, role in Alzheimer s disease, 263 aerobic exercise, panic disorder, 81 agitation, schizophrenia sedation strategies, 21 agomelatine,
More informationPRESCRIBING GUIDELINES
The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors
More informationAnti-Depressant Medications
Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change
More informationSafe transfer of prescribing guidance
Safe transfer of prescribing guidance TEWV Prescriber Summary Application required before prescribing Products requiring an application, before prescribing, using the single application form Unlicensed
More informationNew Patient Questionnaire
4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with
More informationOut with the Old In with the New: Novel, Neuroscience-Based Re-Classification of Psychiatric Medications
Program Outline Out with the Old In with the New: Novel, Neuroscience-Based Re-Classification of Psychiatric Medications Rajiv Tandon, MD Professor of Psychiatry University of Florida College of Medicine
More informationSAMPLE REPORT MENTAL HEALTH DNA INSIGHT LABORATORY INFO. Protected Health Information. SSRIs. TCAs. Other Antidepressants
Test Results Reviewed & Approved by: Laboratory Director, Nilesh Dharajiya,.D. ENTAL HEALTH DNA INSIGHT PERSONAL DETAILS DOB Jan 1, 19XX ETHNICITY Caucasian ORDERING HEALTHCARE PROFESSIONAL Glenn Braunstein.D.
More informationManual of Clinical Psychopharmacology
Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School
More informationPsychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get
More information2015 Update on Psychotropics
2015 Update on Psychotropics Jeffrey T. Apter, M.D. August 2015 Princeton Medical Institute 256 Bunn Drive, Suite 6, Princeton NJ (609) 921-6050 Learning Objectives Upon completion of this session, participants
More informationHEDIS BEHAVIORAL HEALTH RESOURCE GUIDE
HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE What is HEDIS? 3 HEDIS Reference Guide for Behavioral Health 4 Behavioral Health HEDIS Measures 13 WHAT IS HEDIS? HEDIS (Healthcare Effectiveness Data and Information
More informationStudy Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
More informationDrugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD
Drugs, Sleep & Wakefulness Brian Koo Reena Mehra MD MS Kingman Strohl MD Things To Keep In Mind Many drugs effect sleep either causing insomnia or sedation Disruption of sleep and wakefulness may not be
More information176 Stahl s Illustrated. in this web service Cambridge University Press
Stahl s Illustrated acamprosate, 104, 122 3, 148, 149 acceptance and commitment therapy (ACT), 135, 139, 147, 153 accidents, and risk of PTSD, 36 adherence, to medication by PTSD patients with traumatic
More informationSchedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
More informationPHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES
PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES Table of Contents Print TABLE OF CONTENTS Drug Page Number Anafranil... 2 Asendin... 4 Celexa... 4 Cymbalta... 6 Desyrel... 8 Effexor...10 Elavil...14
More informationPSYCHIATRY DRUG ALERTS
M.J. Powers & Co. Continuing Education PSYCHIATRY DRUG ALERTS Target Audience This activity is intended for physicians and other healthcare providers who are involved with or have an interest in the management
More informationThings You Might Not Know About Psychotropic Medications But Wish You Did
Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and
More informationMood Disorders.
Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More information3. Atypical antidepressants
3. Atypical antidepressants Bupropion, mirtazapine, nefazodone & trazodone. Mixed group that act at several different sites. Bupropion Acts as a weak dopamine & NE reuptake inhibitor. Has short half-life.
More informationMixing and Matching: Layering Medications as Family Physicians
Mixing and Matching: Layering Medications as Family Physicians Family Medicine Forum Vancouver, B.C. November 9-12, 2016. Jon Davine, CCFP, FRCP(C) McMaster University Objectives Discuss different examples
More informationPOSTPARTUM MOOD DISORDERS Identification and Treatment Cheryl Carroll CNM, PMHNP Psych Retreat Greensboro, NC
POSTPARTUM MOOD DISORDERS Identification and Treatment Cheryl Carroll CNM, PMHNP 2017 Psych Retreat Greensboro, NC Postpartum Depression DSM 5 Major Depressive Disorder Diagnostic Criteria specifer: with
More informationNSFT Formulary. Double Red Not recommended for routine use/not commissioned. These drugs have not been recommended for routine use at present.
Traffic Light Status NSFT Formulary Not recommended for routine use/not commissioned. These drugs have not been recommended for routine use at present. Hospital/Specialist only Drugs for which the Trust
More informationPregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)
Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned
More informationGUIDELINES FOR THE USE OF PSYCHOACTIVE MEDICATIONS IN INDIVIDUALS WITH CO-OCCURRING SUBSTANCE USE DISORDERS
City and County of San Francisco Mayor Gavin Newsom Department of Public Health Community Behavioral Health Services 1380 Howard Street 5 th Floor San Francisco, CA 94103 GUIDELINES FOR THE USE OF PSYCHOACTIVE
More informationDepression in Late Life
Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist Key Learnings Robert Madan MD FRCPC Key Learnings By the end of the session, participants will be able to List the symptoms of depression
More informationOverview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
More informationThis document has been produced in collaboration with the Lancashire Commissioning Support Unit
Joint for Psychotropic Medication. This document has been produced in collaboration with the Lancashire Commissioning Support Unit Date: December 2014. Reviewed August 2016. Next review Date April 2019
More informationAugmentation and Combination Strategies in Antidepressants treatment of Depression
Augmentation and Combination Strategies in Antidepressants treatment of Depression Byung-Joo Ham, M.D. Department of Psychiatry Korea University College of Medicine Background The response rates reported
More informationAppendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
More informationJoint Formulary for Psychotropic Medication.
Joint for Psychotropic Medication. This document has been produced in collaboration with the Lancashire Commissioning Support Unit Page 1 Table of Contents Section Page Number Page 2 Definition of categories
More informationWeighty Issues with Psychotropic Use in Adolescents and Young Adults
Weighty Issues with Psychotropic Use in Adolescents and Young Adults Sheila Botts, PharmD, BCPP, FCCP Chief, Clinical Pharmacy Research & Academic Affairs Kristen N. Gardner, PharmD Clinical Pharmacy Specialist
More informationTreatment-resistant depression in primary care
Treatment-resistant depression in primary care Interprofessional CME, October 2017 Brian J. Mickey, MD, PhD Associate Professor School of Medicine Department of Psychiatry Disclosures Speakers bureau:
More informationCONTRAINDICATIONS TABLE
CONTRAINDICATIONS TABLE Generic Name Brand Name Contraindications Amphetamine Salts Adderall, Adderall XR Hypersensitivity to amphetamine, dextroamphetamine, or other sympathomimetic amines Advanced arteriosclerosis
More informationPaediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK).
Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK). Childhood pharmacokinetics Children have greater hepatic capacity More glomerular filtration Less fatty tissue Less ability to store
More informationPSYCHIATRY ALERTS CHILD& ADOLESCENT. Severe Mood Dysregulation or Bipolar Disorder?
Aripiprazole Augmentation in OCD...69 CHILD& ADOLESCENT PSYCHIATRY ALERTS INDEX...70 Methylphenidate-Associated Priapism...68 Reference Guide...70 Severe Mood Dysregulation...67 Volume XII / December 2010
More informationPsychopharmacology: A Comprehensive Review
Psychopharmacology: A Comprehensive Review 1) The association between a chemical compound and its biological activity, pioneered by Bovet and colleagues in the 1930s is known as a) Symbiosis b) Structure-activity
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More information48 th Annual Meeting. Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5. Disclosure. Depression. Patient Case. Objectives 7/19/2014
48 th Annual Meeting Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Published in 2013 Most published treatment guidelines
More informationMedically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
More informationMental illness A Broad Overview. Dr H Pathmanandam March 2017
Mental illness A Broad Overview Dr H Pathmanandam March 2017 Introduction Mental disorders are common in primary and secondary care Many are not recognised and not treated Some receive unnecessary or inappropriate
More informationAntidepressant Selection in Primary Care
Antidepressant Selection in Primary Care R E B E C C A D. L E W I S, D O O O A S U M M E R C M E B R A N S O N, M O 1 5 A U G U S T 2 0 1 5 Objectives Understand the epidemiology of depression. Recognize
More informationPSYCHIATRY DRUG ALERTS
M.J. Powers & Co. Continuing Education PSYCHIATRY DRUG ALERTS Target Audience This activity is intended for physicians and other healthcare providers who are involved with or have an interest in the management
More informationPsychiatric Medication Guide
Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants
More informationMedication management of anxiety & depression. Dr Katie Simpson GP Mental health lead East Berks CCG
Medication management of anxiety & depression Dr Katie impson GP Mental health lead East Berks CCG NICE guidelines for Anxiety tepped Care RIs and NRIs in Anxiety disorders RI ertraline Citalopram Fluoxetine
More informationPerinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs
Perinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs (Version 3 January 2015) Principal Author: Dr Jenny Cooke Consultant Psychiatrist, Brighton & Hove Perinatal Mental Health Service
More informationMO Medicaid Foster Care Drugs FY10-FY14
MO Medicaid Foster Care Drugs FY10-FY14 Medicaid (MO HealthNet) Cost of Drugs given to Missouri Foster Care Children by combinations of Age, Gender, Drug Class and Fiscal Year [Raw Data Provided by Missouri
More informationBRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.
BRIEF ANTIDEPRESSANT OVERVIEW Casey Gallimore, Pharm.D., M.S. Antidepressant Medication Classes First Generation Tricyclic Antidepressants (TCAs) Monoamine Oxidase Inhibitors (MAOIs) Second Generation
More informationSupplementary Online Content
Supplementary Online Content Renoux C, Vahey S, Dell Aniello S, Boivin J-F. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol. Published
More informationRetrospective Drug Use Review for the Use of Psychotropic Medications in Children
Retrospective Drug Use Review for the Use of Psychotropic Medications in Children Recommendations Send providers an annual request for additional clinical data for children receiving any of the following
More informationDepression. University of Illinois at Chicago College of Nursing
Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors
More informationMEDICATION ALGORITHM FOR ANXIETY DISORDERS
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences MEDICATION ALGORITHM FOR ANXIETY DISORDERS RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL PSYCHIATRY UNIVERSITY OF WASHINGTON
More informationOptimal Treatment of Anxiety Disorders
Optimal Treatment of Anxiety Disorders Franklin R. Schneier, MD Co-Director, Anxiety Disorders Clinic Research Psychiatrist New York State Psychiatric Institute Special Lecturer in Psychiatry Columbia
More informationMedication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford
Medication for Anxiety and Depression PJ Cowen Department of Psychiatry, University of Oxford Topics Medication for anxiety disorders Medication for first line depression treatment Medication for resistant
More informationPsychobiology Handout
Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are
More informationThe Maudsley Prescribing Guidelines in
The Maudsley Prescribing Guidelines in 11th Edition David Taylor Director of Pharmacy and Pathology South London and Maudsley NHS Foundation Trust; Professor King's College London, London, UK Paton Chief
More informationAnswer ALL questions. For each question, there is ONE correct answer. Use the answer grid provided for ALL your answers.
CLINICAL THERAPEUTICS 7: PSYCHIATRY PHA-MHBY Time allowed: 2 hours UNIVERSITY OF EAST ANGLIA School of Pharmacy Main Series UG Examination 2013-2014 Part ONE Answer ALL questions. For each question, there
More informationEffective Health Care Program
Comparative Effectiveness Review Number 43 Effective Health Care Program Off-Label Use of Atypical Antipsychotics: An Update Executive Summary Background Antipsychotics medications are approved by the
More informationPsychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI
Regional Affective Disorders Service Psychopharmacology Northumberland, Tyne and Wear NHS Trust Hamish McAllister-Williams Reader in Clinical Psychopharmacology Department of Psychiatry, RVI Intro NOT
More informationAffective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018
Affective or Mood Disorders Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Reactive Depression. Secondary: Medical Neurological Drugs Major (Endogenous) Depression = Unipolar: Depressed
More informationAntidepressant Selection in Primary Care
Antidepressant Selection in Primary Care Rebecca D. Lewis, DO OOA Summer CME Oklahoma City, OK 6 August 2017 Objectives Understand the epidemiology of depression. Recognize factors to help choose antidepressants.
More informationHappy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?
Happy Daisy Ltd. New Client intake Form Name Date Preferred name Pronouns Referred by Date of birth Age Race What are the issues for which you are seeking care? 1. 2. 3. Please check of any of the symptoms
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services DEPRESSION Pharmacological Treatment of Depression NICE guidelines suggest the following stepped care model also
More informationClinical Guideline for the Management of Bipolar Disorder in Adults
Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:
More informationGuidelines on Choice and Selection of Antidepressants for the Management of Depression
Guidelines on Choice and Selection of Antidepressants for the Management of Depression 1. Introduction This guidance should be considered as part of a stepped care approach in the management of depressive
More informationNorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
More informationRiding the Waves: Tools for the Management of Bipolar Disorder
Riding the Waves: Tools for the Management of Bipolar Disorder Jacintha S. Cauffield, Pharm.D., BCPS, CDE Associate Professor of Pharmacy Practice Palm Beach Atlantic University Lloyd L. Gregory School
More informationAntidepressant Treatment of Depression
Antidepressant Treatment of Depression PLEASE REFER TO INTEGRATED CARE PATHWAY FOR INFORMATION RELATING TO THE OVERALL MANAGEMENT OF DEPRESSION SSRI s are first choice agents because they are as effective
More informationDementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist
Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution
More informationSteps for Initiating Electroconvulsive Therapy Treatment
Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral
More informationMedication Audit Checklist- Antipsychotics - Atypical
Medication Audit checklist Page 1 of 7 10-2018 Audit number: Client number: Ordering Provider: INDICATIONS 1) Disorders with psychotic symptoms (schizophrenia, schizoaffective disorder, manic disorders,
More informationDISEASES AND DISORDERS
DISEASES AND DISORDERS 13. The mood (affective) disorders 99 14. The psychotic disorders: schizophrenia 105 15. The anxiety and somatoform disorders 111 16. Dementia and delirium 117 17. Alcohol and substance-related
More informationBIOLOGICAL TREATMENT IN PSYCHIATRY. PTE ÁOK Dept.of Psychiatry Pécs
BIOLOGICAL TREATMENT IN PSYCHIATRY PTE ÁOK Dept.of Psychiatry Pécs 1 SGA effects pharmacokinetic effect chemical strucrure Receptor block D2 5-HT2 α1 H-1 M Selectíve DA (D2D3) antagonists Benzamids Amisulpiride
More information